Biofilm Calculators

0 calculators tagged with “Biofilm”

A biofilm is a structured community of microorganisms — predominantly bacteria — attached to a surface and encased in a self-produced matrix of extracellular polymeric substances (EPS) consisting of polysaccharides, proteins, extracellular DNA, and lipids. Biofilms are the predominant mode of microbial life in nature and in medicine — from dental plaque and river stones to chronic wounds and infected medical implants. Bacteria in biofilms are dramatically more resistant to antibiotics and host immune defenses than their planktonic (free-swimming) counterparts, making biofilm-associated infections among the most challenging to treat.

All Calculators

No calculators found for this topic.

Biofilm Formation: Stages

  1. Initial attachment: Planktonic bacteria reversibly attach to a surface — driven by van der Waals forces, hydrophobic interactions, and surface appendages (pili, flagella). This stage is reversible.
  2. Irreversible attachment: Bacteria produce adhesins (surface proteins) that tightly anchor to the substrate. Biofilm formation is now committed.
  3. Early biofilm development: Cell division and EPS matrix production begins. Microcolony clusters form.
  4. Biofilm maturation: Three-dimensional architecture develops with towers, mushroom-shaped structures, and water channels that distribute nutrients and remove waste. Quorum sensing coordinates community behavior.
  5. Dispersal: Cells detach from the biofilm surface as planktonic cells to colonize new surfaces — essential for spread.

EPS Matrix

The extracellular polymeric substance (EPS) matrix constitutes ~70–90% of biofilm biomass. It:

  • Provides structural integrity
  • Protects against antibiotics (physical barrier, binding/neutralizing agents)
  • Retains extracellular enzymes and nutrients
  • Facilitates horizontal gene transfer (including resistance genes)

Antibiotic Resistance in Biofilms

Biofilm bacteria are 10–1,000× more tolerant to antibiotics than planktonic cells due to:

  • Diffusion limitation — EPS matrix slows antibiotic penetration
  • Slow growth / metabolic dormancy — many antibiotics target actively dividing cells
  • Persister cells — small subpopulation in deep dormancy that survives even high antibiotic concentrations
  • Altered gene expression — biofilm-specific regulation changes susceptibility profiles

Clinical Significance

Biofilm infections include: dental caries and periodontitis; chronic otitis media; cystic fibrosis lung infections (Pseudomonas aeruginosa); chronic wound infections; and device-associated infections on catheters, prosthetic joints, heart valves, and contact lenses. These often require mechanical removal (debridement, device replacement) as antibiotics alone are insufficient.

Glossary

Biofilm
A structured community of microorganisms attached to a surface and enclosed in a self-produced extracellular polymeric substance (EPS) matrix. Bacteria in biofilms are 10–1,000× more resistant to antibiotics than planktonic cells.
EPS (Extracellular Polymeric Substance)
The matrix produced by biofilm bacteria consisting of polysaccharides, proteins, extracellular DNA, and lipids. Constitutes ~70–90% of biofilm biomass. Provides structural integrity, antibiotic tolerance, and facilitates horizontal gene transfer.
Persister Cells
A small subpopulation of bacteria in metabolic dormancy within biofilms that survive antibiotic treatment at concentrations lethal to most cells. Upon antibiotic removal, persisters can resume growth and repopulate the biofilm, causing relapsing infections.

Frequently Asked Questions

A biofilm is a structured community of bacteria attached to a surface and encased in a self-produced EPS matrix. Formation follows five stages: (1) initial reversible attachment; (2) irreversible adhesin-mediated attachment; (3) EPS production and microcolony formation; (4) maturation into a 3D architecture with water channels and quorum-sensing-coordinated behavior; (5) dispersal of planktonic cells to colonize new surfaces. Biofilms are the dominant mode of bacterial life in virtually all natural and clinical environments.

Biofilm bacteria are 10–1,000× more tolerant to antibiotics than planktonic cells. Key mechanisms: (1) the EPS matrix slows antibiotic diffusion and can bind/neutralize some agents; (2) slow growth and metabolic dormancy in deeper biofilm layers reduce effectiveness of antibiotics that target active processes; (3) persister cells — a small subpopulation in deep dormancy — survive even lethal antibiotic concentrations and can repopulate the biofilm; (4) biofilm-specific gene expression alters susceptibility profiles.

Quorum sensing is a bacterial cell-to-cell communication system using diffusible chemical signals (autoinducers). As bacterial density increases, autoinducer concentration rises until it reaches a threshold, triggering coordinated changes in gene expression across the population. In biofilms, quorum sensing coordinates EPS production, virulence factor secretion, motility, and the transition from biofilm to dispersal state. Quorum sensing inhibitors are being investigated as anti-biofilm strategies.

Biofilm-associated infections include: dental plaque leading to caries and periodontitis; Pseudomonas aeruginosa lung biofilms in cystic fibrosis (a leading cause of morbidity); chronic non-healing wounds; catheter-associated urinary tract infections (CAUTIs); central line-associated bloodstream infections (CLABSIs); prosthetic joint infections; and infective endocarditis on heart valves. Device-associated biofilm infections are notoriously difficult to treat and often require hardware removal combined with prolonged antibiotic therapy.